Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series

Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series / Guerrieri, S., Rubin, M., Gattuso, I., Zanetta, C., Genchi, A., Preziosa, P., Rocca, M.A., Filippi, M., Moiola, L.. - In: JOURNAL OF NEUROLOGY. - ISSN 0340-5354. - 271:6(2024), pp. 3678-3681. [10.1007/s00415-024-12342-z]